Novartis Q3: Jimenez talks up Alcon, Gleevec takes generic hammering

October 24, 2017
Manufacturing and Production, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of …

alessandro-riva

Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head

October 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

handshake

Eisai banks on potential of Biogen’s Alzheimer’s drug

October 24, 2017
Manufacturing and Production, Sales and Marketing

Drug developers investigating Alzheimer’s drugs know that they’re taking a gamble; there have been numerous big failures that have caused …

pounds_stacked

ADC Therapeutics brings in $200 million of financing

October 24, 2017
Manufacturing and Production, Sales and Marketing ADC Therapeutics, AstraZeneca, biotech, drugs, pharma, pharmaceutical

ADC Therapeutics has won some serious financial support after its latest financing round managed to net the company $200 million. …

Recipharm equips Lisbon facility for US and European serialisation

October 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …

lauritzen1_k100

Securing the cold chain with new solutions

October 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cold chain, manufacturing, supply chain

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …

save_our_nhs

Pharma companies accused of charging NHS twice for treatments

October 23, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

A new report published by STOP AIDS and Global Justice Now takes aim at three pharmaceutical companies who have taken …

antibiotics

Public Health England sounds warning against overuse of antibiotics

October 23, 2017
Medical Communications, Sales and Marketing Antibiotics, biotech, drugs, pharma, pharmaceutical

Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …

GSK’s shingles vaccine scores US approval

October 23, 2017
Sales and Marketing FDA, GSK, Shingrix, pharma, shingles

GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …

MSD cuts 1,800 jobs in US operations restructure

October 23, 2017
Manufacturing and Production, Sales and Marketing MSD, Merck, job cuts, pharma

MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …

baby_powder

$417 million case against J&J thrown out

October 23, 2017
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, talc

A judge in California has thrown out the lawsuit made by a woman who had alleged that Johnson & Johnson’s …

pollution_smoke

Report reveals impact of pollution, with 9m deaths worldwide

October 20, 2017
Medical Communications biotech, drugs, pharma, pharmaceutical, pollution

A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …

dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …

teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017
Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …

celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017
Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …

donor_card

Worrying number of organ donations blocked by families

October 19, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …

portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

The Gateway to Local Adoption Series

Latest content